<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d217">
    <sentence id="DDI-DrugBank.d217.s0" text="Elevated plasma levels of theophylline have been reported with concomitant quinolone use.">
        <entity id="DDI-DrugBank.d217.s0.e0" charOffset="26-37"
            type="drug" text="theophylline"/>
        <entity id="DDI-DrugBank.d217.s0.e1" charOffset="75-83"
            type="group" text="quinolone"/>
        <ddi id="DDI-DrugBank.d217.s0.d0" e1="DDI-DrugBank.d217.s0.e0"
            e2="DDI-DrugBank.d217.s0.e1" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d217.s1" text="There have been reports of theophylline-related side effects in patients on concomitant therapy with norfloxacin and theophylline.">
        <entity id="DDI-DrugBank.d217.s1.e0" charOffset="27-38"
            type="drug" text="theophylline"/>
        <entity id="DDI-DrugBank.d217.s1.e1" charOffset="101-111"
            type="drug" text="norfloxacin"/>
        <entity id="DDI-DrugBank.d217.s1.e2" charOffset="117-128"
            type="drug" text="theophylline"/>
        <ddi id="DDI-DrugBank.d217.s1.d0" e1="DDI-DrugBank.d217.s1.e1"
            e2="DDI-DrugBank.d217.s1.e2" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d217.s2" text="Therefore, monitoring of theophylline plasma levels should be considered and dosage of theophylline adjusted as required.">
        <entity id="DDI-DrugBank.d217.s2.e0" charOffset="25-36"
            type="drug" text="theophylline"/>
        <entity id="DDI-DrugBank.d217.s2.e1" charOffset="87-98"
            type="drug" text="theophylline"/>
    </sentence>
    <sentence id="DDI-DrugBank.d217.s3" text="Elevated serum levels of cyclosporine have been reported with concomitant use of cyclosporine with norfloxacin.">
        <entity id="DDI-DrugBank.d217.s3.e0" charOffset="25-36"
            type="drug" text="cyclosporine"/>
        <entity id="DDI-DrugBank.d217.s3.e1" charOffset="81-92"
            type="drug" text="cyclosporine"/>
        <entity id="DDI-DrugBank.d217.s3.e2" charOffset="99-109"
            type="drug" text="norfloxacin"/>
        <ddi id="DDI-DrugBank.d217.s3.d0" e1="DDI-DrugBank.d217.s3.e1"
            e2="DDI-DrugBank.d217.s3.e2" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d217.s4" text="Therefore, cyclosporine serum levels should be monitored and appropriate cyclosporine dosage adjustments made when these drugs are used concomitantly.">
        <entity id="DDI-DrugBank.d217.s4.e0" charOffset="11-22"
            type="drug" text="cyclosporine"/>
        <entity id="DDI-DrugBank.d217.s4.e1" charOffset="73-84"
            type="drug" text="cyclosporine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d217.s5" text="Quinolones, including norfloxacin, may enhance the effects of oral anticoagulants, including warfarin or its derivatives or similar agents.">
        <entity id="DDI-DrugBank.d217.s5.e0" charOffset="0-9"
            type="group" text="Quinolones"/>
        <entity id="DDI-DrugBank.d217.s5.e1" charOffset="22-32"
            type="drug" text="norfloxacin"/>
        <entity id="DDI-DrugBank.d217.s5.e2" charOffset="67-80"
            type="group" text="anticoagulants"/>
        <entity id="DDI-DrugBank.d217.s5.e3" charOffset="93-100"
            type="drug" text="warfarin"/>
        <ddi id="DDI-DrugBank.d217.s5.d0" e1="DDI-DrugBank.d217.s5.e0"
            e2="DDI-DrugBank.d217.s5.e2" type="effect"/>
        <ddi id="DDI-DrugBank.d217.s5.d1" e1="DDI-DrugBank.d217.s5.e0"
            e2="DDI-DrugBank.d217.s5.e3" type="effect"/>
        <ddi id="DDI-DrugBank.d217.s5.d2" e1="DDI-DrugBank.d217.s5.e1"
            e2="DDI-DrugBank.d217.s5.e2" type="effect"/>
        <ddi id="DDI-DrugBank.d217.s5.d3" e1="DDI-DrugBank.d217.s5.e1"
            e2="DDI-DrugBank.d217.s5.e3" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d217.s6" text="When these products are administered concomitantly, prothrombin time or other suitable coagulation tests should be closely monitored."/>
    <sentence id="DDI-DrugBank.d217.s7" text="The concomitant administration of quinolones including norfloxacin with glyburide (a sulfonylurea agent) has, on rare occasions, resulted in severe hypoglycemia.">
        <entity id="DDI-DrugBank.d217.s7.e0" charOffset="34-43"
            type="group" text="quinolones"/>
        <entity id="DDI-DrugBank.d217.s7.e1" charOffset="55-65"
            type="drug" text="norfloxacin"/>
        <entity id="DDI-DrugBank.d217.s7.e2" charOffset="72-80"
            type="drug" text="glyburide"/>
        <entity id="DDI-DrugBank.d217.s7.e3" charOffset="85-102"
            type="group" text="sulfonylurea agent"/>
        <ddi id="DDI-DrugBank.d217.s7.d0" e1="DDI-DrugBank.d217.s7.e0"
            e2="DDI-DrugBank.d217.s7.e2" type="effect"/>
        <ddi id="DDI-DrugBank.d217.s7.d1" e1="DDI-DrugBank.d217.s7.e1"
            e2="DDI-DrugBank.d217.s7.e2" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d217.s8" text="Therefore, monitoring of blood glucose is recommended when these agents are co-administered."/>
    <sentence id="DDI-DrugBank.d217.s9" text="Diminished urinary excretion of norfloxacin has been reported during the concomitant administration of probenecid and norfloxacin.">
        <entity id="DDI-DrugBank.d217.s9.e0" charOffset="32-42"
            type="drug" text="norfloxacin"/>
        <entity id="DDI-DrugBank.d217.s9.e1" charOffset="103-112"
            type="drug" text="probenecid"/>
        <entity id="DDI-DrugBank.d217.s9.e2" charOffset="118-128"
            type="drug" text="norfloxacin"/>
        <ddi id="DDI-DrugBank.d217.s9.d0" e1="DDI-DrugBank.d217.s9.e1"
            e2="DDI-DrugBank.d217.s9.e2" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d217.s10" text="The concomitant use of nitrofurantoin is not recommended since nitrofurantoin may antagonize the antibacterial effect of Norfloxacin in the urinary tract.">
        <entity id="DDI-DrugBank.d217.s10.e0" charOffset="23-36"
            type="drug" text="nitrofurantoin"/>
        <entity id="DDI-DrugBank.d217.s10.e1" charOffset="63-76"
            type="drug" text="nitrofurantoin"/>
        <entity id="DDI-DrugBank.d217.s10.e2" charOffset="121-131"
            type="drug" text="Norfloxacin"/>
        <ddi id="DDI-DrugBank.d217.s10.d0" e1="DDI-DrugBank.d217.s10.e1"
            e2="DDI-DrugBank.d217.s10.e2" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d217.s11" text="Multivitamins, or other products containing iron or zinc, antacids or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.">
        <entity id="DDI-DrugBank.d217.s11.e0" charOffset="0-12"
            type="group" text="Multivitamins"/>
        <entity id="DDI-DrugBank.d217.s11.e1" charOffset="44-47"
            type="drug" text="iron"/>
        <entity id="DDI-DrugBank.d217.s11.e2" charOffset="52-55"
            type="drug" text="zinc"/>
        <entity id="DDI-DrugBank.d217.s11.e3" charOffset="58-65"
            type="group" text="antacids"/>
        <entity id="DDI-DrugBank.d217.s11.e4" charOffset="70-79"
            type="drug" text="sucralfate"/>
        <entity id="DDI-DrugBank.d217.s11.e5" charOffset="172-182"
            type="drug" text="norfloxacin"/>
        <entity id="DDI-DrugBank.d217.s11.e6" charOffset="273-283"
            type="drug" text="norfloxacin"/>
        <ddi id="DDI-DrugBank.d217.s11.d0" e1="DDI-DrugBank.d217.s11.e0"
            e2="DDI-DrugBank.d217.s11.e5" type="advise"/>
        <ddi id="DDI-DrugBank.d217.s11.d1" e1="DDI-DrugBank.d217.s11.e1"
            e2="DDI-DrugBank.d217.s11.e5" type="advise"/>
        <ddi id="DDI-DrugBank.d217.s11.d2" e1="DDI-DrugBank.d217.s11.e2"
            e2="DDI-DrugBank.d217.s11.e5" type="advise"/>
        <ddi id="DDI-DrugBank.d217.s11.d3" e1="DDI-DrugBank.d217.s11.e3"
            e2="DDI-DrugBank.d217.s11.e5" type="advise"/>
        <ddi id="DDI-DrugBank.d217.s11.d4" e1="DDI-DrugBank.d217.s11.e4"
            e2="DDI-DrugBank.d217.s11.e5" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d217.s12" text="Videx (Didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because these products may interfere with absorption resulting in lower serum and urine levels of norfloxacin.">
        <entity id="DDI-DrugBank.d217.s12.e0" charOffset="0-4"
            type="brand" text="Videx"/>
        <entity id="DDI-DrugBank.d217.s12.e1" charOffset="7-16"
            type="drug" text="Didanosine"/>
        <entity id="DDI-DrugBank.d217.s12.e2" charOffset="178-188"
            type="drug" text="norfloxacin"/>
        <entity id="DDI-DrugBank.d217.s12.e3" charOffset="289-299"
            type="drug" text="norfloxacin"/>
        <ddi id="DDI-DrugBank.d217.s12.d0" e1="DDI-DrugBank.d217.s12.e0"
            e2="DDI-DrugBank.d217.s12.e2" type="advise"/>
        <ddi id="DDI-DrugBank.d217.s12.d1" e1="DDI-DrugBank.d217.s12.e1"
            e2="DDI-DrugBank.d217.s12.e2" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d217.s13" text="Some quinolones have also been shown to interfere with the metabolism of caffeine.">
        <entity id="DDI-DrugBank.d217.s13.e0" charOffset="5-14"
            type="group" text="quinolones"/>
        <entity id="DDI-DrugBank.d217.s13.e1" charOffset="73-80"
            type="drug" text="caffeine"/>
        <ddi id="DDI-DrugBank.d217.s13.d0" e1="DDI-DrugBank.d217.s13.e0"
            e2="DDI-DrugBank.d217.s13.e1" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d217.s14" text="This may lead to reduced clearance of caffeine and a prolongation of its plasma half-life.">
        <entity id="DDI-DrugBank.d217.s14.e0" charOffset="38-45"
            type="drug" text="caffeine"/>
    </sentence>
</document>
